糖尿病治疗设备，预计到 2028 年

Diabetes Care Devices, Forecast to 2028

出版日期: 2024年05月31日 | 出版商:

Frost & Sullivan | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

AI 和 GLP-1 成长机会推动第 2 型糖尿病 (T2D) 治疗设备的扩张

这项研究详细概述了全球糖尿病治疗设备产业，由于各地区糖尿病盛行率不断上升，该产业的需求显着增加。市场竞争激烈，既有老牌公司，也有新兴Start-Ups。 OEM正在开发创新产品，以加强糖尿病护理，并将其客户群从第 1 型糖尿病 (T1D) 患者扩展到包括第 2 型糖尿病 (T2D)、糖尿病前期，甚至非糖尿病患者。公司正在采用新颖的商务策略产生稳定的收益来源并减轻患者的经济负担。研究将糖尿病治疗设备分为两大类：血糖值监测和胰岛素输送。血糖值监测设备由自我血糖监测（SMBG）设备和连续血糖监测（CGM）系统组成，胰岛素输送设备由胰岛素帮浦和胰岛素笔组成。我们还根据糖尿病类型（T1D 和 T2D）对行业进行细分，以检验每种糖尿病类型的独特市场趋势。地理范围包括北美、欧洲、亚太地区 (APAC)、中东和非洲、南亚 (MEASA) 和拉丁美洲。这项研究提供了与所有细分市场相关的预测、规模和趋势分析。我们研究了竞争格局，并重点介绍了对该领域产生影响的主要企业和关键技术。我们确定每个细分市场的成长动力和限制因素，并分析该行业变化带来的机会。基准年为2023年，预测期间为2024年至2028年。

This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped technology to enhance diabetes care and expand the customer base beyond patients with type 1 diabetes (T1D) to those with type 2 diabetes (T2D), prediabetes, and even those without diabetes. Companies are adopting novel business strategies that create steady revenue streams and ease patients' financial burdens. The study segments diabetes care devices into two main categories: glucose monitoring and insulin delivery. Glucose monitoring devices comprise self-monitoring of blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems, while insulin delivery devices comprise insulin pumps and insulin pens. The study also segments the industry according to diabetes type (T1D and T2D), examining the unique market dynamics of each. The geographic scope includes North America, Europe, Asia-Pacific (APAC), the Middle East, Africa, and South Asia (MEASA), and Latin America. The study provides relevant forecast, sizing, and trend analyses across all segments. It examines the competitive landscape and highlights the key players and significant technologies making an impact in this space. The study identifies the factors driving and restraining growth in each segment and analyzes the opportunities emerging from the changes in this industry for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Diabetes Care Device Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Key Competitors
Growth Metrics
Distribution Channels
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Segment
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share by Segment
Competitive Environment
Revenue Share
Revenue Share Analysis

Trends in the Diabetes Care Continuum

Global Diabetes Prevalence
New Business Models
Care Setting Trends
Eco-friendly Management
Metabolic Health
New Insulin Delivery Systems
AI Integration in Diabetes Care

T1D Opportunities

T1D Patient Journey
Children and Adolescents with T1D in China
Growth Opportunity: CGM for T1D Children and Adolescents in China
China: Market Analysis and Penetration Approach
Additional Ways to Address T1D Patient Needs

T2D Opportunities

T2D Patient Journey
Global T2D Prevalence
T2D: A Global Health Concern
Reimbursement for T2D
Opportunities in T2D Presented by GLP-1
Insulin Pump Growth Opportunities in T2D

Emerging Companies

Diabeloop's DBLG1 Algorithm for Insulin Delivery
Decide Clinical Software's GlucoTab

Growth Opportunity Analysis: SMBG

SMBG Growth Metrics
SMBG Growth Drivers
SMBG Growth Restraints
SMBG Revenue Forecast
SMBG Revenue Forecast by Region
SMBG Competitors
SMBG Forecast Analysis

Growth Opportunity Analysis: CGM

CGM Growth Metrics
CGM Growth Drivers
CGM Growth Restraints
CGM Revenue Forecast
CGM Revenue Forecast by Region
CGM Key Competitors
CGM Reimbursement Trends and Market Shifts
Diversifying CGM User Base
CGM Forecast Analysis

Growth Opportunity Analysis: Insulin Pens

Insulin Pen Growth Metrics
Insulin Pen Growth Drivers
Insulin Pen Growth Restraints
Insulin Pen Revenue Forecast
Insulin Pen Revenue Forecast by Region
Insulin Pen Key Competitors
Insulin Pen Reimbursement Trends and Market Shifts
Insulin Pen Forecast Analysis

Growth Opportunity Analysis: Insulin Pumps

Insulin Pump Growth Metrics
Insulin Pump Growth Drivers
Insulin Pump Growth Restraints
Insulin Pump Revenue Forecast
Insulin Pump Revenue Forecast by Region
Insulin Pump Key Competitors
Insulin Pump Reimbursement Trends and Market Shifts
Insulin Pump Forecast Analysis

Growth Opportunity Universe

Growth Opportunity 1: Insulin Pumps for T2D patients
Growth Opportunity 2: Wearables for the Multiparametric Testing of Glucose and Lipids
Growth Opportunity 3: Eco-friendly Insulin Pens
Growth Opportunity 4: CGM for T1D Children and Adolescents in China
Growth Opportunity 5: AI-based Early Diagnosis Tools and Tests